Serum levels of brain-derived neurotrophic factor (BNDF) in multiple sclerosis patients with Trichuris suis ova therapy

We previously analysed clinical and immunological parameters under Trichuris suis ova (TSO) therapy in four patients with secondary progressive multiple sclerosis. The serum Brain-derived neurotrophic factor (BDNF) levels of these four patients were assessed before, during and after therapy with TSO...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosche, Berit, Werner, Jonas, Benzel, Friderike Joëlle, Harms, Lutz, Danker-Hopfe, Heidi, Hellweg, Rainer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: EDP Sciences 2013
Materias:
Short Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866952/
https://www.ncbi.nlm.nih.gov/pubmed/24351232
http://dx.doi.org/10.1051/parasite/2013056
Descripción
Sumario:We previously analysed clinical and immunological parameters under Trichuris suis ova (TSO) therapy in four patients with secondary progressive multiple sclerosis. The serum Brain-derived neurotrophic factor (BDNF) levels of these four patients were assessed before, during and after therapy with TSO and showed significant decrease of BDNF during TSO therapy (p < 0.05).

Ejemplares similares